Background: Several genetic variants have been associated with the susceptibility to
variants associated with allergic diseases, such as atopic dermatitis (eg, COL6A5, 3 16 ). 1 A meta-analysis of genomewide association studies (GWAS) in 53 862 individuals has identified 16 shared genomewide loci significantly associated with self-reported pollen allergy, dust mite allergy, and cat allergy. 17 Of these loci, 8 had previously been associated with asthma. Genetic variants that were found to be associated with self-reported allergy included loci encoded in the 4p14 region near TLR1 (Toll-like receptor 1), TLR6 (Toll-like receptor 6), and TLR10 (Toll-like receptor 10). Those genes encode patternrecognition receptors that play a role in recognizing external molecules and are involved in innate immunity and immune responses.
Genetic variation in TLR6 has also been shown to increase the risk of high total IgE in children having two or more older siblings. 18 Other associations in the GWAS meta-analysis included loci in genes involving in the presentation of intracellular peptides to T cells, genes involved in the initiation of skin immune responses, TH2 differentiation (BCL6, IL2/ADAD1), cell-cell adhesion (LPP), and genes involved in the regulation of TH2-mediated inflammation and mucus production in allergic airway disease. 17 To summarize the combined effect of genetic variants on an outcome, such as the susceptibility of allergies, a genetic risk score (GRS)
can be constructed. A GRS-sometimes called allele scores, gene scores, or genotype scores-comprises of a quantitative score of previously associated SNPs. 19 Although most of the genetics studies for allergies were performed in adults, the collective dataset suggests an important genetic basis for allergic diseases. This raises the question whether genetic risk factors associated with allergic diseases in adults are predictive for the development of allergic diseases in children as well. In this current study, we aimed to develop a GRS for the onset of allergy in children based on findings in adults, to study whether genetic risk factors for allergy later in life are also predictive for the risk of developing allergies early in life.
| METHODS

| Study population
We analyzed data collected in the Wheezing Illnesses Study Leidsche Rijn (WHISTLER) cohort, a prospective population-based birth cohort study in the Netherlands, which studies determinants and prediction of wheezing illnesses. Study design and rationale of WHISTLER have been described in detail elsewhere. 20 Briefly, healthy neonates and infants born in a newly developed residential area near the city of Utrecht in the Netherlands (ie, Leidsche Rijn)
were invited by telephone to participate in this study before the age of 2 months. Exclusion criteria were gestational age <36 weeks, major congenital abnormalities, and neonatal respiratory disease.
During an extended first consultation, an "Individual Health Profile" (IHP) was compiled and buccal swabs were obtained for DNA extraction. Children were followed throughout childhood. At the age of 5 years, children were invited for a second study visit to the local outpatient clinic, in which information about general health, allergic 
| Study design
In this population-based birth cohort, we assessed the association between a genetic risk score for allergy susceptibility based on genetic variants associated with allergy in adults and allergies (parental-reported and doctor-diagnosed) in children.
| Genotyping and quality control
Genomic DNA was extracted from buccal cells of infants using the QIAamp DNA blood mini kit (Qiagen, GmbH, Hilden, Germany), and concentration was determined using PicoGreen (Molecular Probes, Thermofisher scientific, Waltham, MA, USA). 20 Genotyping was performed using the Infinium HumanExome chip (Illumina, San Diego, CA), version 1.1, which contains 242 902 variants. 21 Genotypes obtained from GenomeStudio were used for quality control (QC), and PLINK v1.07 was used for the downstream process. Sample QC was performed on common SNPs (MAF ≥5%) of high quality (missingness < 1%, Hardy-Weinberg equilibrium P > 1e−4, and LD-pruned to leave no pairs with r 2 > .2). We removed samples based on heterozygosity, keeping samples within 4 standard deviations. European ancestry was verified using EIGENSTRAT, 22 and non-European samples were excluded for further analysis. Identity-by-descent estimates from PLINK were used to identify siblings or otherwise related children (pi-hat >0.2), one of which was randomly excluded. As the calling algorithms in GenomeStudio are not designed for rare SNPs, genotypes from zCall 23 were used in subsequent analyses, where we excluded SNPs with a call rate less than 95% and a Hardy-Weinberg equilibrium P-value < 1e−6.
| Genetic risk score
A GRS was constructed based on SNPs previously associated with allergies in adults in a GWAS meta-analysis by Hinds et al, 17 as there were no GWAS available for children. In this meta-analysis, common self-reported allergy phenotypes (pollen allergy, dust mite allergy, and cat allergy) in two cohorts with a total of 53 862 individuals.
Of the 16 identified shared susceptibility loci with association P < 5e−8, reported by Hinds et al, three were available on the exome chip. Moreover, we found a suitable alternative on the chip for seven more SNPs, for which our criterion was that they should have an r 2 > .8.
The r 2 could be regarded as the correlation between the original and the alternative SNP, as a rough measure, with r 2 = .8; in 80% of the cases, if you have genotyped the original SNP, you will also have information on the correlated SNP. Therefore, we could include 10 SNPs in our GRS. We weighted the SNPs in proportion to their effect size, as these varied considerably between the SNPs. The weighting was based on the natural logarithm of the reported odds ratios (ORs) for the allergy SNPs in the original GWAS. 17 The GRS was weighted in such a way that an increase in the GRS would be associated with an increase in allergies in the original GWAS. SNPs included in the risk score, as well as effect sizes, effect alleles, references to studies identifying them, and detail on generating GRS can be found in the supplementary materials (Table S1 ).
| Outcomes
1. Parental-reported allergy to pollens, dust mites, and/or pets at age 5. This was based on ≥1 positive answer to one of the following questions in the questionnaire during the study visit at age 5 and age 8: "Is your child allergic to pollen?", "Is your child allergic to house dust mite?", "Is your child allergic to certain pets?"
Physician diagnosis of allergic symptoms, using the International
Classification of Primary Care (ICPC), 24 allergic conjunctivitis (ICPC: F71), allergic rhinitis (ICPC: R97), or eczema/dermatitis (ICPC: S87, S88). These data were collected from the primary healthcare records.
| Statistical analysis
Logistic regression analysis was applied to study the association between the GRS and the parental-reported allergies at age 5 and age 8. Odds ratios (ORs), 95% confidence intervals (CI), and p-values were calculated, and the model was adjusted for age, gender, breastfeeding, and a family history of asthma or allergy. To study the association between the GRS and physician diagnosis of allergic symptoms, a Cox regression analysis was used, as data were available regarding the timing of physician diagnosis of allergic symptoms. Hazard ratios, 95% CI, and P-values were calculated, and the model was adjusted for age, gender, breastfeeding, and a family history of asthma or allergy. The agreement between parentalreported allergy (to specific allergens) and physician-diagnosed allergy (based on allergic symptoms) was assessed with Cohen's kappa statistics and interpreted using the classification system developed by Landis and 
| RESULTS
| Study population
In total, 2112 children who participated in the WHISTLER study were genotyped, of which 692 were excluded in the genotyping QC process, leaving 1420 children for our analyses. The high exclusion rate of the genetic samples was mainly due to large amount of related individuals in the WHISTLER cohort. Physician diagnosis data during follow-up were available for 1330 children, and parental-reported data at ages 5 and 8 were available for 465 and 163 children, respectively ( Figure 1 and Table S2 ). Characteristics of the study population are shown in Table 1 .
The median age of our study population was 7.0 years (interquartile range (IQR): 4.0-9.0), and half of the children were girls (50.8%). The mean genetic risk score of the children in the study was 0.7 ± 0.28. 
| GRS and parental-reported allergies
| GRS and physician-diagnosed allergy
We retrospectively assessed the time to a physician-diagnosed allergy in the WHISTLER population. The median follow-up time was Table 3) . Children with higher allergy GRS had a higher chance to be diagnosed with allergic conjunctivitis, rhinitis, or dermatitis during the follow-up. The effect of GRS on diagnosed allergic conjunctivitis or rhinitis separately was not statistically significant (HR = 1.90, 95% CI: 0.6-5.9).
| The agreement between parental-reported and physician-diagnosed allergies
For 455 children, data were available to assess the agreement between diagnosed allergies (allergic conjunctivitis, allergic rhinitis, or dermatitis at age 5 years) and parental-reported allergy to pollen, house mites, or pets at age 5. Overall agreement was 70.5% (Table 4) ; kappa was 0.10 (95% CI: 0.03-0.18), which indicated "slight agreement." There was also a slight agreement (62.9%) at age 8 (Table 5 ) with a kappa of 0.14 (95% CI: 0.02-0.26). When dermatitis would be left out of the physiciandiagnosed allergy outcome, the agreement was 94.9% (Table S3 ) with kappa statistics of 0.49 at 5 years old and 89.1% (Table S4) 
| DISCUSSION
This study showed that genetic variants previously associated with allergies in adults are also predictive of the onset of allergies in children.
Development of allergic diseases is complex. Both environmental factors such as diet, family size, education level in the household, specific infections, exposures to non-pathogenic microorganisms, living in urban settings and regions with low exposure to ultraviolet radiation and low humidity, 26 and genetic factors have been shown to be involved. 2 A century ago, it was already shown that there is a heritable component in the risk of developing allergies. 27 More recently, large GWAS have identified genetic variants associated with allergic sensitization and allergic symptoms. 17, 28 Here, we showed that combining established genetic risk factors in a predictive risk score can be used to predict the onset of allergy in children.
That a GRS might be a useful tool to predict allergies has also been shown by Bønnelykke et al. 28 They constructed a GRS based on 10 genomewide significant loci based on a different, somewhat smaller, reference GWAS 29 including 10 studies (birth cohorts and populationbased cohorts). They tested the predictive capacity of the GRS for allergic sensitization and allergic rhinitis in a population-based study (n = 9258, mostly adults) and showed that a higher GRS score indicated a higher prevalence of sensitization. In our study, we applied a similar approach but restricted the GRS to genetic variants associated with allergy in adults and tested the GRS in an independent birth cohort to assess the predictive value for allergies early in life.
Nevertheless, there is a large overlap in the loci studied; of the ten loci Bønnelykke et al studied, 5 loci were also included in our study.
A complete report of similarity and differences of the two mentioned reference GWAS was published by Bønnelykke et al. 29 The comparability of different genetic allergy studies is limited due to the application of different definitions of allergy 1 ; some studies focus on allergic symptoms and use self-reported allergy, and others focus on physician diagnosis of allergy or measures of allergic sensitization such as elevated levels of allergen-specific IgE and/or a positive skin prick test. Although allergic sensitization can be measured more objectively, it does not provide proof that the sensitization will also cause allergic symptoms. In this study, we assessed allergic symptoms, focusing on self/parental-reported, as well as physician-diagnosed allergies. As both outcomes might measure different aspects of allergic diseases, we performed agreement analyses to see whether these outcomes identified different individuals. We found a slight statistically significant agreement between reported allergy to pollen, house mites, or pets and diagnosed allergies. We assume that one of the reasons for the lack of agreement is that not all children visit their physician with allergic complaints. Nevertheless, the GRS was associated with parental-reported allergy (at age 5), as well as physician-diagnosed allergy (during follow-up). In summary, an allergy GRS based on SNPs associated with allergies in adults can predict the risk on developing allergies in childhood. As allergy has multiple risk factors including genetic components, we believe that this allergy GRS can be used to develop a prediction model for allergic symptoms.
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